Saturday, 17 April 2004
Organiser C.A.B. Boucher (Utrecht, The Netherlands)

Contribution of host and virus in the determination of HIV pathogenesis

Saturday Morning
Chairs C.A.B. Boucher (Utrecht, The Netherlands) abstract number
08.30 – 09.15 Sialoadhesin mRNA is expressed in CD14+ cells in blood and is upregulated after HIV-infection
M. Cornelissen (Amsterdam, The Netherlands)
09.15 – 10.00 CD4 T cell depletion by hyperactivation?
R. de Boer (Utrecht, The Netherlands)
10.00 – 11.15 coffee break + plenary lecture
11.30 – 12.15 T cell dynamics in HIV pathogenesis
F. Miedema (Amsterdam, The Netherlands
12.15 – 12.30 Dual effect of Highly Active Anti-Retroviral Therapy during acute HIV-1 infection: long-term rescue of cytokine production and proliferation of HIV-specific CD4+ T cells
C.A. Jansen, I..M. De Cuyper, R. Steingrover, S. Jurriaans, S. Sankatsing J. Prins, D. Van Baarle, and F. Miedema (Amsterdam, The Netherlands)
12.30 – 12.45 Immunological effects of combined treatment with Mycophenolate Mofetil and HAART in acute and chronic HIV-1 infected, treatment naïve patients
N. Vrisekoop, S.U.C. Sankatsing, C.A. Jansen, M.T.L. Roos, S.A. Otto, H. Schuitemaker, J.M.A. Lange, F. Miedema, and J.M. Prins (Amsterdam, The Netherlands)
12.45 – 13.00 discussion
13.00 – 14.00 lunch / poster viewing
Saturday afternoon
Chair C.A.B. Boucher Utrecht, The Netherlands) Abstract number
14.00 – 14.45 Fitness and evolution of HIV-1 during antiretroviral therapy
M. Nijhuis (Utrecht, The Netherlands)
14.45 – 15.00 Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behavior
F.A. Koning, C.A. Jansen, J. Dekker, N. Dukers, R.A. Kaslow, M. Prins, D. van Baarle, and H. Schuitemaker (Amsterdam, The Netherlands; Birmingham, AL, USA)
15.00 – 15.30 Coffee break
15.30 – 16.15 Title to be announced
A.D.M.E. Osterhaus (Rotterdam, The Netherlands)
16.15 – 17.00 discussion
17.00 end of workshop
Development of a novel rapid assay to determine HIV-1 fitness-differences in patients failing protease inhibitor treatment
N.M. van Maarseveen, D. de Jong, A.M. Smits, R. Schuurman, C.A.B. Boucher, and M. Nijhuis (Utrecht, The Netherlands)
Reverse transcription fitness assay by quantitative determination of intermediate HIV-1 reverse transcription cDNA products in PBMCs
M. Huigen, L. de Graaf, D. Eggink, J. den Dunnen, C. Boucher, R. Schuurman, and M. Nijhuis (Utrecht, The Netherlands)